ANCA-associated vasculitis trials in Germany

In Germany 9 Also abroad 97

9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
Treatment of patients with autoantibody-positive autoimmune diseases and severe interstitial lung fibrosis with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector - a single center Phase I/II clinical trial (HD-CAR-ILD-1)
Where
Heidelberg
Age
18 years and over
People
10
Run by
Universitaetsklinikum Heidelberg AöR
See details and how to join2024-519592-26-00 · EU 2024-519592-26-00
No phaseTaking people
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Where
Kirchheim unter Teck
People
700 worldwide
Run by
University of Pennsylvania
See details and how to joinNCT00315380
Phase 1/2Not yet taking people in Germany
An open-label phase I/II, single-center, interventional singlearm basket trial of UKT-CART19.1 in patients with relapsed/refractory autoimmune diseases
Where
Tuebingen
Age
18 years and over
People
36
Run by
Universitaetsklinikum Tuebingen AöR
See details and how to join2024-519491-60-00 · EU 2024-519491-60-00
Phase 2Taking people
Rescue of Nephrons With ALE.F02 (RENAL-F02)
Where
Berlin, Cologne, Dresden, Essen, Hanover, Leipzig, Lübeck, München
Age
18 years and over
People
80 worldwide
Run by
Alentis Therapeutics AG
See details and how to joinNCT06047171
Phase 4Taking people
Discontinuation of rituximab compared with rituximab maintenance in ANCA-associated vasculitis – a randomized non-blinded controlled trial (DISRITUX)
Where
DO NOT EDIT
Age
18 years and over
People
130 worldwide
Run by
Region Oestergoetland
See details and how to join2023-508398-10-00 · EU 2023-508398-10-00
Phase 1/2Taking people
An open label, phase I/II study investigating the safety and efficacy of a CD3/CD20 bispecific T-cell engager therapy in patients with active, treatment refractory, ANCA-IgG-positive associated vasculitis. The RENEWAL study
Where
Berlin
Age
18 years and over
People
8
Run by
Fraunhofer Institute For Translational Medicine And Pharmacology ITMP
See details and how to join2025-522853-21-01 · EU 2025-522853-21-01
No phaseTaking people
Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Where
Bonn
Age
18 years and over
People
120
Run by
University of Bonn
See details and how to joinNCT07150000
No phaseTaking people
AYLo - AutoimmunitY and Loss of y
Where
Bonn
Age
50 years and over
People
500
Run by
University of Bonn
See details and how to joinNCT06696027
Phase 1/2Not yet taking people in Germany
Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis
Where
Berlin
Age
18 years to 75 years
People
8
Run by
David Simon
See details and how to joinNCT06590545 · EU 2024-517303-36-00